Mr. William A. Nuerge has 30 years medical/pharmaceutical industry experience. Bill is the former CEO and Executive Board Member of Xanodyne Pharmaceuticals, Inc. He has served on several advisory boards for companies providing pharmaceutical operational and regulatory compliance services, including Buzzeo Associates, LTD, PDMA Inc., and he currently serves on the Board of Xanodyne, Cutanogen Corporation, and Supernus Pharmaceuticals, Inc.

Bill began his pharmaceutical career in 1978 with Lafayette Pharmaceuticals (originally a division of Alcon Laboratories) as a quality control chemist and microbiologist. Over the 16 plus years he served with Lafayette, Bill held several positions of increasing responsibility culminating with the position of General Manager and Vice President of Operations. In 1994, Bill joined Richwood Pharmaceuticals Company, Inc. as Chief Operating Officer. In 1997, Richwood merged with Shire and Bill was subsequently promoted to President and CEO of Shire US. During his tenure, Shire US grew to over $1 billion and became one of the most successful specialty pharmaceutical companies.

Bill holds a Bachelor's of Science degree from Purdue University. While at Purdue, he also completed two years postgraduate study in management and business law. In April 2004, he was named a Purdue "Distinguished Alumni." Bill received his MBA from Indiana Wesleyan University where he was voted the "Outstanding Professional" of his MBA graduating class.